{"disease":{"id":"immune-related-colitis","name":"immune related colitis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06841705","title":"Early Vedolizumab as First-Line for Immune-Related Colitis Therapy Trial","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Shilpa Grover, MD, MPH","has_results":false},{"nct_id":"NCT06074874","title":"Intestinal Biomarker Analysis After ECP for ICI Colitis","phase":"","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"University of Freiburg","has_results":false},{"nct_id":"NCT05414552","title":"ECP for Immune-related Adverse Events After Checkpoint Inhibitor Treatment","phase":"","overall_status":"COMPLETED","enrollment_count":11,"lead_sponsor_name":"University of Freiburg","has_results":false},{"nct_id":"NCT05726396","title":"A Pilot Study Testing the Safety and Feasibility of Restorative Microbiota Therapy (RMT) in Patients With Refractory Immune-checkpoint Inhibitor-related Colitis","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"University of Minnesota","has_results":false},{"nct_id":"NCT06646016","title":"EPIC- Extracorporeal Photopheresis (ECP) for Immune-related Colitis","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Therakos LLC","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}